EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Significantly enhancing human antibody affinity via deep learning and computational biology-guided single-point mutations

Junxin Li, Chao Zhang, Wei Xia, Hei Wun Kan, Kaifang Huang, Sai Li, Mark Akinola Ige, Qiuliyang Yu, Jiawei Zhao, Xiaochun Wan, John Z H Zhang iD, Haiping Zhang iD

Briefings in Bioinformatics · 2025

DOI: 10.1093/bib/bbaf445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2025. Verfasst von Junxin Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of S…. Hauptthemen laut MEDLINE: Deep Learning, Computational Biology, Antibody Affinity, Point Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Shenzhen Basic Research Fund, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enhancing antibody affinity is a critical goal in antibody design, as it improves therapeutic efficacy, specificity, and safety while reducing dosage requirements. Traditional methods, such as single-point mutations or combinatorial mutagenesis, are limited by the impracticality of exhaustively exploring the vast mutational space. To address this challenge, we developed a novel computational pipeline that integrates evolutionary constraints, antibody–antigen-specific statistical potentials, molecular dynamics simulations, metadynamics, and a suite of deep learning models to identify affinity-enhancing mutations. Our deep learning framework includes MicroMutate, which predicts microenvironment-specific amino acid mutations, and graph-based models that evaluate postmutation antigen–antibody-binding probabilities. Using this approach, we screened 12 single-point mutant antibodies targeting the hemagglutinin of the H7N9 avian influenza virus, starting from antibodies with initial affinities in the subnanomolar range, with one showing a 4.62-fold improvement. To demonstrate the generalizability of our method, we applied it to engineer an antibody against death receptor 5 with initial affinities in the subnanomolar range, successfully identifying a mutant with a 2.07-fold increase in affinity. Our work underscores the transformative potential of integrating deep learning and computational methods for rapidly and precisely discovering affinity-enhancing mutations while preserving immunogenicity and expression. This approach offers a powerful and universal platform for advancing antibody therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep LearningComputational BiologyAntibody AffinityPoint MutationHumansMolecular Dynamics SimulationInfluenza A Virus, H7N9 Subtype

Stichwörter der Autor:innen

antibody affinity maturationdeep learning-based antigen–antibody modelsevolutionary constraintshigh-affinity antibody designmicroenvironment point mutationsingle-point mutation

Autor:innen und Institutionen

  • Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Nanshan District, Shenzhen 518055, China.
  • Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Nanshan District, Shenzhen 518055,…
  • Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, 1 Beizhen Road, Xinhu Subdistrict, Guangming District, Shenzhen 518055, China.
  • Shanghai Frontiers Science Center of Artificial Intelligence and Deep Learning and NYU-ECNU Center for Computational Chemistry, NYU-Shanghai, 1555 Century Avenue, Pudong New Area, Shanghai 200062, China.
  • Department of Chemistry, New York University, New York, NY 10003, United States.
  • School of Chemistry and Molecular Engineering, East China Normal University, 138 Tongpu Road, Putuo District, Shanghai 200062, China.

ORCID-Profile: John Z H Zhang, Haiping Zhang

Förderung

  • Guangdong Basic and Applied Basic Research Foundation
  • Shenzhen Basic Research Fund
  • National Key R&D Program of China
  • National Science Foundation of China
  • Shenzhen Key Projects
  • Shenzhen Science and Technology Program
  • Shenzhen Medical Research Fund

Zitieren

APA

Li, J., Zhang, C., Xia, W., Kan, H. W., Huang, K., Li, S., Ige, M. A., Yu, Q., Zhao, J., Wan, X., Zhang, J. Z. H., & Zhang, H. (2025). Significantly enhancing human antibody affinity via deep learning and computational biology-guided single-point mutations. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf445

Vancouver

Li J, Zhang C, Xia W, Kan HW, Huang K, Li S, et al. Significantly enhancing human antibody affinity via deep learning and computational biology-guided single-point mutations. Briefings in Bioinformatics. 2025. doi:10.1093/bib/bbaf445

BibTeX
@article{Li2025,
  author = {Li, Junxin and Zhang, Chao and Xia, Wei and Kan, Hei Wun and Huang, Kaifang and Li, Sai and Ige, Mark Akinola and Yu, Qiuliyang and Zhao, Jiawei and Wan, Xiaochun and Zhang, John Z H and Zhang, Haiping},
  title = {Significantly enhancing human antibody affinity via deep learning and computational biology-guided single-point mutations},
  journal = {Briefings in Bioinformatics},
  year = {2025},
  doi = {10.1093/bib/bbaf445}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche